Published in Vaccine Weekly, December 6th, 2006
While the timing of an award decision is not known, intensive efforts are underway to conclude the process, according to information the company has received from government officials. Earlier in the year the government announced plans to acquire a new smallpox vaccine for persons who are immune-compromised and at risk for developing serious complications from the smallpox vaccine currently...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.